Scarica l'app Stockscreener
5.84
0.93%
-0.055
Pre-mercato:
5.95
0.11
+1.88%
Precedente Chiudi:
$5.895
Aprire:
$6
Volume 24 ore:
10,689
Relative Volume:
0.55
Capitalizzazione di mercato:
$3.11M
Reddito:
-
Utile/perdita netta:
$-12.52M
Rapporto P/E:
-0.0483
EPS:
-120.8826
Flusso di cassa netto:
$-4.83M
1 W Prestazione:
+6.67%
1M Prestazione:
+0.69%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$5.81
$6.24
Intervallo di 1 settimana:
$5.25
$6.24
Portata 52W:
$5.15
$16.92
Decoy Therapeutics Inc Stock (DCOY) Company Profile
Nome
Decoy Therapeutics Inc
Settore
Industria
Telefono
346-772-0346
Indirizzo
2450 HOLCOMBE BLVD, HOUSTON
Compare DCOY vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DCOY
Decoy Therapeutics Inc
|
5.84 | 3.11M | 0 | -12.52M | -4.83M | -120.88 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Decoy Therapeutics Inc Stock (DCOY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-23 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-04-27 | Iniziato | Ladenburg Thalmann | Buy |
Decoy Therapeutics Inc Borsa (DCOY) Ultime notizie
Decoy Therapeutics to implement 1-for-12 reverse stock split - Investing.com
Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston - BioSpace
Decoy Therapeutics (DCOY) Proxy Filing Summary - Quartr
Decoy Therapeutics Inc (FRA:FP11) Stock PDF (Updated: 2026/04/27) - GuruFocus
Decoy Therapeutics Showcases Novel Antiviral Therapies in Boston - Intellectia AI
Decoy Therapeutics Inc (FRA:FP11) Stock Earnings Transcripts - GuruFocus
Salarius Pharmaceuticals stock tumbles after announcing $7 million discounted public offering - MSN
Is Decoy (DCOY) stock gaining market share | Q3 2024: EPS Tops ViewsHot Market Picks - Cổng thông tin điện tử tỉnh Lào Cai
DCOY Price Today: Decoy Therapeutics Inc. Stock Price, Quote & Chart - MEXC
Decoy Therapeutics Builds Momentum with Accelerating Execution, Entering a Highly Catalytic Phase with a Clearly Defined Path to Clinical Development of its Antiviral Pipeline - BioSpace
Transcript : Decoy Therapeutics Inc.Special Call - marketscreener.com
CEO Rick Pierce to outline Decoy's 2026 outlook in April 9 webcast - Stock Titan
Decoy Therapeutics outlines antiviral pipeline milestones By Investing.com - Investing.com South Africa
Decoy Therapeutics outlines antiviral pipeline milestones - Investing.com
Decoy Therapeutics Launches Multi-Virus Antiviral Platform - Intellectia AI
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
What is the volatility of Decoy (DCOY) Stock | Price at $5.84, Down 0.76%Index Investing - Newser
DCOY Technical Analysis & Stock Price Forecast - Intellectia AI
Decoy Therapeutics to Participate in Virtual Investor Closing Be - GuruFocus
Decoy Therapeutics to Participate in Virtual Investor Closing Bell Event Highlighting Business Outlook for 2026 - Finviz
Is Decoy (DCOY) Stock a Buy Now | DCOY Q4 Earnings: Beats Estimates by $25.32Recovery Stocks - Newser
Decoy Therapeutics Inc (STU:FP11) Stock Earnings Transcripts - GuruFocus
Decoy Therapeutics Inc (STU:FP11) Stock Price & 30 Year Financial Data - GuruFocus
Decoy Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - Bitget
DCOY Stock Analysis: Decoy Therapeutics Inc. Slides 7.5% to $5.8 Key Biotech Trends - Cổng thông tin điện tử tỉnh Tây Ninh
Decoy Therapeutics Inc. (DCOY) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Decoy Therapeutics regains Nasdaq minimum bid price compliance By Investing.com - Investing.com Australia
Decoy Therapeutics regains Nasdaq minimum bid price compliance - Investing.com
Decoy Therapeutics Regains Nasdaq Compliance After Reverse Split - TipRanks
Decoy Therapeutics regains compliance with Nasdaq minimum bid price requirement - marketscreener.com
Decoy Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement - TradingView
Decoy Therapeutics regains Nasdaq minimum bid compliance after reverse split - TradingView
Decoy Therapeutics (DCOY) restores Nasdaq bid-price compliance after reverse split - Stock Titan
DCOY Stock Analysis: Biotech Decoy Therapeutics Inc. Rises 1.43 Percent to 6.62 Dollars - Cổng thông tin điện tử Tỉnh Sơn La
DCOY: 2025 net loss rose to $12.5M, with cash runway into late 2026 but going concern risk persists - TradingView
Decoy Therapeutics 10-K: Net loss $12.52M, EPS $(129.10) - TradingView — Track All Markets
Decoy Therapeutics (NASDAQ: DCOY) details AI antiviral platform, merger and reverse stock splits - Stock Titan
Decoy Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Decoy Therapeutics Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Total liabilities & shareholders' equities of Decoy Therapeutics Inc. – FWB:FP11 - TradingView
Nabriva Therapeutics (NASDAQ:NBRV) and Decoy Therapeutics (NASDAQ:DCOY) Head to Head Survey - Defense World
If You Invested $1,000 in Salarius Pharmaceuticals Inc (SLRX) - Stock Titan
Decoy Therapeutics Inc.: Fundamental Analysis and Financial Ratings | | US79400X6022 - marketscreener.com
Decoy Therapeutics Inc.: Fundamental Analysis and Financial Ratings | FP11 | US79400X6022 - marketscreener.com
Decoy Therapeutics Inc.: Fundamental Analysis and Financial Ratings | DCOY | US79400X6022 - marketscreener.com
Decoy Therapeutics partners with Quantori on AI peptide platform By Investing.com - Investing.com Nigeria
Decoy Therapeutics Enters Strategic Partnership with Quantori to Deploy Google Cloud-native Integrated AI-Driven Peptide Design and Molecular Simulation Platform - Lelezard
Decoy Therapeutics Inc Azioni (DCOY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):